» Articles » PMID: 25426550

MiR-520d-5p Directly Targets TWIST1 and Downregulates the MetastamiR MiR-10b

Overview
Journal Oncotarget
Specialty Oncology
Date 2014 Nov 27
PMID 25426550
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs are key players in most biological processes. Some microRNAs are involved in the genesis of tumors and are therefore termed oncomiRs, while others, termed metastamiRs, play a significant role in the formation of cancer metastases. Previously, we identified ten different cellular microRNAs that downregulate the expression of MICB, a ligand of the activating NK receptor NKG2D. Interestingly, several of the ten MICB-targeting microRNAs, such as miR-10b, are involved in tumor formation and metastasis. In this work, we identify a complex interplay between these different microRNAs. Specifically, we demonstrate that three of the MICB-targeting microRNAs: miR-20a, miR-17-5p and miR-93, also target the same site in the 3'UTR of TWIST1, a transcription factor implicated in cancer metastasis. Additionally, we show that miR-520d-5p targets a different site in the 3'UTR of TWIST1. We next show that the miR-520d-5p-mediated decrease of TWIST1 expression results in reduced expression of one of its targets, miR-10b, and in the restoration of E-Cadherin expression, which in turn results in reduced cellular motility and invasiveness. Finally, we show that miR-520d-5p leads to reduced proliferation of tumor cells, and that high levels of miR-520d-5p correlate with higher survival rates of cancer patients.

Citing Articles

Melatonin and Its Role in the Epithelial-to-Mesenchymal Transition (EMT) in Cancer.

Martinez-Campa C, Alvarez-Garcia V, Alonso-Gonzalez C, Gonzalez A, Cos S Cancers (Basel). 2024; 16(5).

PMID: 38473317 PMC: 10931174. DOI: 10.3390/cancers16050956.


Endothelin-3 is epigenetically silenced in endometrioid endometrial cancer.

Zmarzly N, Januszyk S, Mieszczanski P, Morawiec E, Buda P, Dziobek K J Cancer Res Clin Oncol. 2022; 149(9):5687-5696.

PMID: 36542159 PMC: 10356642. DOI: 10.1007/s00432-022-04525-w.


miR-647 inhibits hepatocellular carcinoma cell progression by targeting protein tyrosine phosphatase receptor type F.

Ye X, Qiu R, He X, Hu Z, Zheng F, Huang X Bioengineered. 2021; 13(1):1090-1102.

PMID: 34969357 PMC: 8805897. DOI: 10.1080/21655979.2021.2017628.


Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature.

Isca C, Piacentini F, Mastrolia I, Masciale V, Caggia F, Toss A Cancers (Basel). 2021; 13(19).

PMID: 34638377 PMC: 8508299. DOI: 10.3390/cancers13194894.


Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients.

Lazaridou M, Gonschorek E, Massa C, Friedrich M, Handke D, Mueller A Oncoimmunology. 2020; 9(1):1774323.

PMID: 32923135 PMC: 7458634. DOI: 10.1080/2162402X.2020.1774323.


References
1.
Guo H, Ingolia N, Weissman J, Bartel D . Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010; 466(7308):835-40. PMC: 2990499. DOI: 10.1038/nature09267. View

2.
Chaffer C, Weinberg R . A perspective on cancer cell metastasis. Science. 2011; 331(6024):1559-64. DOI: 10.1126/science.1203543. View

3.
Stern-Ginossar N, Gur C, Biton M, Horwitz E, Elboim M, Stanietsky N . Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat Immunol. 2008; 9(9):1065-73. DOI: 10.1038/ni.1642. View

4.
Ohuchida K, Mizumoto K, Ohhashi S, Yamaguchi H, Konomi H, Nagai E . Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice. Int J Cancer. 2007; 120(8):1634-40. DOI: 10.1002/ijc.22295. View

5.
Miura N, Sato R, Tsukamoto T, Shimizu M, Kabashima H, Takeda M . A noncoding RNA gene on chromosome 10p15.3 may function upstream of hTERT. BMC Mol Biol. 2009; 10:5. PMC: 2661890. DOI: 10.1186/1471-2199-10-5. View